CBR1 and migraine disorder: An observational, cross-sectional study comparing the binding of CBR-1, as detected by positron emission tomography (PET), among female migraine patients and healthy controls demonstrated a global increase, which was most pronounced in the anterior cingulate, mesial temporal, prefrontal, and superior frontal cortices of the brains of migraineurs [100].